Desktop Site |
24 Apr 24 | 12:32 | Open
Equity SME Eq Drv Currency Commodity Corporates
Get Quote
Notices |
S&P BSE SENSEX 74,033.66 +295.21 +0.40 %
Corporate Announcement
  • Security Code532872
    CompanySun Pharma Advanced Research Company Ltd
    Exchange Disseminated Time
     
     
     Outcome of Board Meeting | 1/27/2017 1:56:24 PM 
     Sun Pharma Advanced Research Company Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 27, 2017, took the following decisions:

    1. Approved the 'Statement of Utilisation' in the use of proceeds from the objects stated in the Offer documents of the recently concluded Rights issue of the Company as on December 31, 2016, which was already reviewed by the Audit Committee in its meeting held earlier during the day.

    2. Accepted the resignation of Mr. Sudhir Valia, as the Chief Financial Officer of the Company with effect from end of working hours on January 31, 2017 and appointed Mr. Chetan Rajpara, presently Vice President - Treasury of Sun Pharmaceutical Industries Limited, as the Chief Financial Officer of the Company w.e.f. February 01, 2017.

    Post his resignation as the Chief Financial Officer of the Company, Mr. Valia will continue to be associated with the Company in his capacity of non-executive director.    		 
     
    << Back  
     
Recently Viewed
Copyright@ 2015. All Rights Reserved. BSE Ltd.
(122H) 24 Apr 24|12:32 (IST)